|
ASPH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.578200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.827800E-01 |
| Normal-vs-Stage2 |
2.512000E-01 |
| Normal-vs-Stage3 |
2.064200E-02 |
| Normal-vs-Stage4 |
1.798230E-02 |
| Stage1-vs-Stage2 |
1.473790E-01 |
| Stage1-vs-Stage3 |
1.753520E-02 |
| Stage1-vs-Stage4 |
1.662220E-02 |
| Stage2-vs-Stage3 |
1.380040E-01 |
| Stage2-vs-Stage4 |
4.768500E-02 |
| Stage3-vs-Stage4 |
3.576600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.073700E-02 |
| Normal-vs-AfricanAmerican |
8.063200E-01 |
| Normal-vs-Asian |
4.623800E-01 |
| Caucasian-vs-AfricanAmerican |
4.339800E-02 |
| Caucasian-vs-Asian |
6.099800E-01 |
| AfricanAmerican-vs-Asian |
4.502400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.924200E-01 |
| Normal-vs-Female |
1.181680E-03 |
| Male-vs-Female |
2.736300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.339790E-01 |
| Normal-vs-Extreme_Weight |
9.961000E-01 |
| Normal-vs-Obese |
5.811900E-02 |
| Normal-vs-Extreme_Obese |
8.519400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.514810E-01 |
| Normal_Weight-vs-Obese |
6.022000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.675400E-01 |
| Extreme_Weight-vs-Obese |
1.018180E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.538800E-01 |
| Obese-vs-Extreme_Obese |
6.074000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.057010E-01 |
| Normal-vs-Age(41-60Yrs) |
5.119600E-02 |
| Normal-vs-Age(61-80Yrs) |
5.220400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.785200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.491800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.429190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.050800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.767400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.896200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.416200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.490400E-02 |
| Normal-VS-Type2 PRCC |
1.712170E-02 |
| Normal-VS-KIRP CIMP |
6.173000E-04 |
| Normal-VS-Unclassified PRCC |
2.690800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.375700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.195900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.503700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.163800E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.989400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.633200E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.626000E-01 |
| Normal-vs-N1 |
2.236500E-03 |
| Normal-vs-N2 |
1.733610E-01 |
| N0-vs-N1 |
7.238400E-03 |
| N0-vs-N2 |
2.449000E-01 |
| N1-vs-N2 |
5.284800E-01 |
|
|
